Dengue virus neutralization in cells expressing Fc gamma receptors

PLoS One. 2013 May 22;8(5):e65231. doi: 10.1371/journal.pone.0065231. Print 2013.

Abstract

Activating Fc gamma receptors (FcγRs) in hematopoietic cells serve to remove antibody-opsonized antigens, including dengue virus (DENV), from systemic circulation. While neutralizing antibody concentrations provide humoral immunity, cross-reactive or sub-neutralizing levels of antibody can result in antibody-dependent enhancement of DENV infection that increases overall viral burden. Recently, it has been suggested that the antibody levels needed for DENV neutralization differs when different FcγR is engaged. If this is true, the threshold titer used to infer immunity should be influenced by FcγR usage. Here, using cells that express both activating and inhibitory FcγRs, we show that the type of FcγR engaged during phagocytosis can influence the antibody concentration requirement for DENV neutralization. We demonstrate that phagocytosis through FcγRI requires significantly less antibody for complete DENV neutralization compared to FcγRIIA. Furthermore, when DENV is opsonized with sub-neutralizing levels of antibody, FcγRI-mediated phagocytosis resulted in significantly reduced DENV titers compared to FcγRIIA. However, while FcγRI may remove antibody-opsonized DENV more efficiently, this receptor is only preferentially engaged by clustering when neutralizing, but not sub-neutralizing antibody concentrations, were used. Collectively, our study demonstrates that activating FcγR usage may influence antibody titers needed for DENV neutralization.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antibodies, Neutralizing / immunology*
  • Blotting, Western
  • Cell Line
  • Dengue Virus / growth & development
  • Dengue Virus / immunology*
  • Flow Cytometry
  • Humans
  • Neutralization Tests
  • Phagocytosis
  • RNA, Small Interfering / genetics
  • Receptors, IgG / immunology*
  • Viral Plaque Assay

Substances

  • Antibodies, Neutralizing
  • RNA, Small Interfering
  • Receptors, IgG

Grants and funding

This work was supported by the Singapore National Research Foundation under its Clinician Scientist Award administered by the National Medical Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.